First Manhattan’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
2023
Q3
$6.19M Hold
2023
Q2
$6.16M Hold
2023
Q1
$7.3M Sell
2022
Q4
$21.5M Buy
2022
Q3
$22.7M Hold
2022
Q2
$19.1M Buy
2015
Q4
Sell
2015
Q3
$57K Buy